In D’Iberville, those battling Parkinson’s Disease are slipping on the gloves and fighting back thanks to SAAD Healthcare’s Rock Steady Boxing classes.
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
If Terry Sandquist had his way, he’d continue work as a probation officer for McLeod County at least two more years. “Originally, I had thought even longer,” he said. But after 10 years ...
A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...
MPs and campaigners say that people suffering from Motor Neurone Disease or Parkinson’s should have greater access to an ...
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback